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Abstract
Priority setting of health interventions is generally considered as a valuable approach to support low- and 
middle-income countries (LMICs) in their strive for universal health coverage (UHC). However, present 
initiatives on priority setting are mainly geared towards the development of more cost-effectiveness information, 
and this evidence does not sufficiently support countries to make optimal choices. The reason is that priority 
setting is in reality a value-laden political process in which multiple criteria beyond cost-effectiveness are 
important, and stakeholders often justifiably disagree about the relative importance of these criteria. Here, we 
propose the use of ‘evidence-informed  deliberative processes’ as an approach that does explicitly recognise 
priority setting as a political process and an intrinsically complex task. In these processes, deliberation between 
stakeholders is crucial to identify, reflect and learn about the meaning and importance of values, informed by 
evidence on these values. Such processes then result in the use of a broader range of explicit criteria that can be 
seen as the product of both international learning (‘core’ criteria, which include eg, cost-effectiveness, priority 
to the worse off, and financial protection) and learning among local stakeholders (‘contextual’ criteria). We 
believe that, with these evidence-informed deliberative processes in place, priority setting can provide a more 
meaningful contribution to achieving UHC.  
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Introduction
In January 2016, the Prince Mahidol Award Conference 
(PMAC) in Thailand brought together more than 900 delegates 
from 60 different countries, to discuss priority setting of health 
interventions to achieve universal health coverage (UHC).1 
The goal of UHC is to ensure that all people obtain the health 
services they need, without suffering financial hardship 
when paying for them.2 At the conference, the World Health 
Organization (WHO) and the Disease Control Priority (DCP) 
project presented their impressive work to expand the evidence 
base on the cost-effectiveness of interventions, concentrated on 
low- and middle-income countries (LMICs).3,4 The underlying 
implicit assumption to these analyses is that priority setting 
should be geared towards maximisation of population health, 
and that the provision of more evidence on cost-effectiveness 
will improve decision-making and lead to better health. This 
rationale also underpins the development of many international 
disease control guidelines. For example, the most recent WHO 
guidelines on when to start antiretroviral therapy for HIV are 
largely based on the expected epidemiological impact and cost-
effectiveness.5 
In this editorial, we argue that the mere provision of cost-
effectiveness information does not adequately support countries 
to make optimal choices. The reason is that priority setting is in 
reality a value-laden political process, in which multiple criteria 
beyond cost-effectiveness are important and stakeholders often 
justifiably disagree about their relative importance. Instead, we 
propose the use of ‘evidence-informed deliberative processes’ 
as an approach that does explicitly recognise priority setting 
as a political process and an intrinsically complex task. In 
these processes, deliberation between stakeholder is crucial 
to identify, reflect and learn about the importance of relevant 
values, informed by evidence on these values. 
We first outline the need for evidence-informed deliberative 
processes, illustrate this with examples from Indonesia, 
Thailand, and the Netherlands, discuss how to preserve the use 
of social core values in these processes, and then elaborate on 
their use to achieve UHC.
The Need for Evidence-Informed Deliberative Processes
It has been recognised since long that priority setting is in 
reality a value-based political process which takes place in 
an environment of social values and diverging interests.6-10 
It involves “pluralistic bargaining between different lobbies, 
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modified by shifting political judgements made in the light of 
changing pressures”11 and is described as “a complex interaction 
of various decisions at diverse levels in the organization. There 
is no self-obvious set of ethical principles or scientific tools to 
determine what decisions we should take at various levels.”12 
If we agree that priority setting is a value-based political 
process, this then requires a paradigm shift in how research 
should approach the challenge of priority setting, addressing 
two important issues. Firstly, society – including relevant 
stakeholders such as patients, providers, insurers, and citizens 
– has a wide range of social values to judge decisions. These 
go beyond only health maximization as reflected in the 
criterion ‘cost-effectiveness,’ for example caring for the worse 
off in society or responsibility for own health.13-18 We argue 
that the whole of these values should be considered when 
setting priorities. Second, stakeholders often disagree about 
the importance of these values, and may have good reasons to 
do so when it comes to setting priorities. In the light of this, 
Daniels and Sabin have proposed the use of fair processes as an 
alternative approach to priority setting. In their seminal work 
on ‘accountability for reasonableness’ (A4R), they argue that 
it is more likely that stakeholders will agree on a fair process 
to set priorities than on the use of specific social values – and 
if they do so, stakeholders are then also more likely to confer 
legitimacy to the decisions that are made through this process.10 
Following this logic, and in acceptance of these two issues, the 
central question in priority setting becomes: ‘How can priority 
setting processes be organised such that stakeholders confer 
legitimacy to the decisions that will eventually be taken’? Or in 
other words: ‘so that they accept these decisions as reasonable?’ 
Daniels and Sabin propose conditions for transparency, 
relevance, appeal, and enforcement that processes should meet 
to achieve legitimacy.10 The aim of such processes is to develop 
a mutual basis for decisions among stakeholders, through the 
identification, interpretation and deliberation on a range of 
values that they find important, and informed by evidence 
where possible. 
Where Daniels and Sabin speak of ‘fair processes,’ we preferably 
name these ‘evidence-informed deliberative processes’ to better 
position the approach in the present public health debate. 
On the one hand, these processes are based on deliberation 
between stakeholders to identify, reflect and learn about the 
meaning and importance of relevant social values. On the other 
hand, they are based on rational decision-making – through 
evidence-informed evaluation of the identified values where 
possible. We speak of evidence-informed rather than evidence-
based evaluation as the former concept leaves ample room for 
clinical experience as well as the constructive judgements of 
stakeholders such as practitioners and patients who are in 
constant interaction and dialogue with one another.19 We see 
‘evidence-informed’ and ‘deliberation’ as the two essential 
elements to achieve legitimacy in priority setting. To date, the 
work on fair processes (or how we name it: evidence-informed 
deliberative processes), has mainly been theoretical, and we 
see large potential for their practical application to support 
countries in their strive for UHC. 
Development of Evidence-Informed Deliberative Processes 
We distinguish six steps in the use of evidence-informed 
deliberative processes (Figure), and these are described in detail 
elsewhere.20 The dotted lines reflect that the process is iterative. 
Figure. Six Steps of Evidence-Informed Deliberative Processes.
The way these steps can be applied in a decision-making context 
to foster the legitimacy of the eventual decisions, depend on 
the already existing priority setting process. To illustrate this, 
we provide two examples: (i) a case study to support HIV 
control in Indonesia, where priority setting has historically 
been implicit and entire processes need to be established; (ii) 
reimbursement decisions in the Netherlands and Thailand 
where HTA agencies are firmly established, and processes 
are relatively well-developed. It is obvious that in the former 
example, there is a relatively large need and large potential to 
improve the legitimacy of decisions, as compared to the latter 
example.
Supporting HIV Control in Indonesia 
We recently supported West Java provincial authorities in 
Indonesia in the development of their strategic plan on 
HIV/AIDS.20-23 The process included a situational analysis 
on the current response to the HIV epidemic (step 1); the 
formation of a multi-stakeholder consultation panel (step 2); 
the identification of stakeholder values for the most important 
goals in HIV control, resulting in a set of criteria for priority 
setting that were considered reasonable by all panel members 
(step 3); a listing of HIV/AIDS intervention options by the 
consultation panel, including the collection of evidence to 
assess their performance (step 4); a deliberative discussion 
among the consultation panel members on this evidence, 
in view of their values and interests, to reach agreement on 
the final rank order of interventions (step 5); and a listing of 
institutions that would be suitable and/or fund high priority 
interventions (step 6). The overall aim of the process was to 
organise priority setting as an interactive learning process, in 
which the consultation panel refined the participatory steps 
of identifying, elaborating and deciding on the inclusion of 
further relevant stakeholders, criteria and evidence. A recent 
evaluation indicated that panel members were overall positive 
about the process, as it had improved the quality of decision-
making ̶ especially in terms of use of multiple criteria and 
concrete evidence, active participation of stakeholders, and 
transparency of decision-making.22,23
Yet, we also recognize that, for logistic and budgetary reasons, 
it is not feasible to develop such processes from scratch in all 
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decision-making contexts where no priority setting process is in 
place. Ideally, countries should work towards the development 
of more generic centrally-led institutionalized processes, 
which would then be used at decentralised level as guidance for 
priority setting.24,25 We see our work as a stepping stone towards 
such institutionalized processes, by spelling out important 
principles, documenting the initial experiences, and thereby 
creating awareness about its potential and limitations. In this 
context, we applaud the pioneering work of the International 
Decision Support Initiative (iDSI), which provides policy-
makers at sub-national, national, regional, and international 
levels with technical support in coordinating priority setting as 
a means towards achieving UHC.25 
Reimbursement Decisions by Health Technology Assessment 
Agencies 
A number of national health technology assessment (HTA) 
agencies have already important components of evidence-based 
deliberative processes in place. For example, the Netherlands 
Health Care Institute (ZINL) employs an appraisal committee 
that represents the Dutch society and advises the Minister of 
Health. The committee deliberates on the social value of health 
technologies on the basis of the available evidence on four 
generic criteria (effectiveness, cost-effectiveness, necessity, 
and feasibility), along with other contextual criteria that are 
considered relevant to the interventions under scrutiny.26 
In Thailand, the National Health Security Office employs 
a consultation panel which works with a large group of 
stakeholders to select interventions for assessment. The panel 
appraises the interventions on several criteria and deliberates 
to reach consensus on which interventions should be adopted 
in the benefit package.27 While these agencies employ various 
elements of evidence-based deliberative processes, they can 
still improve on other elements eg, stakeholder involvement in 
the Netherlands. This in order to further foster the legitimacy 
of their decisions. 
From a more methodologically point of view: various 
approaches to priority setting contain important elements of 
evidence-informed deliberative processes, including A4R,10 
multi-criteria decision analysis (MCDA)28 and programme 
budgeting and marginal analysis (PBMA).29,30 The frameworks 
have been applied in various settings.27,31-36 The added value 
of our framework is that it combines these elements in an 
integrated approach.
The Use of Social ‘Core’ Values to Achieve Universal Health 
Coverage 
An important issue in the use of evidence-informed 
deliberative processes is how important social values can be 
preserved in the process. Stakeholder consultation, especially 
in the presence of vested interests, does not necessarily capture 
such public interests. 
In its report ‘Making fair choices on the path to UHC,’ the WHO 
recently proposed the use of ‘cost-effectiveness,’ ‘priority to the 
worse off,’ and ‘financial protection’ as the three most essential 
criteria for countries to consider when setting priorities.18 
We consider these as ‘core’ criteria, representing social values 
for which there is broad consensus on their importance and 
which are of generic relevance across countries, disease areas 
and health interventions. Their identification can be seen as 
the product of international learning, particularly in academic 
circles, on priority setting.37 One way to preserve these ‘core’ 
values in evidence-informed deliberative processes is to 
consider them as mandatory criteria for healthcare priority 
setting. Another, less stringent option is to use them as ‘opt-
out’ criteria, for which a decision-maker should provide 
compelling arguments when declining them. We argue that 
the use of evidence-informed deliberative processes would 
then be instrumental to consider additional criteria for priority 
setting for which there is no broad consensus or which are only 
relevant for a particular decision – we call these ‘contextual 
criteria.’ These can include many criteria, eg, ‘responsibility for 
own health’ or ‘size of the population affected.’37
Above we criticize WHO and the DCP project for its use of 
cost-effectiveness analysis as the sole criterion. Yet, how we 
see it, ‘cost-effectiveness’ can very well be a ‘core’ criterion in 
priority setting but should be interpreted in the context of 
other stakeholder values. In other words, our critique concerns 
the dominant use of cost-effectiveness analysis, not cost-
effectiveness analysis as such. In fact, the DCP project is now 
conducting extended cost-effectiveness analysis (ECEA), to 
also capture the financial protection which interventions offer 
to target populations.38 We applaud this effort as it provides 
valuable evidence on what we see as one of the core criteria 
in priority setting to achieve UHC. Yet, we recommend that 
this DCP work should be coupled with the development of 
evidence-informed deliberative processes at the country level, 
to also identify other contextual criteria.22 
Our Contribution
As a research group, we carry out various activities under the 
heading of the REVISE (REthinking the Value of Interventions 
to improve priority SEtting) project to further develop 
evidence-informed deliberative processes.39 We are:
•	 developing best practices on the various elements of 
these processes, eg, on whose values to consider, how to 
best guide the identification of criteria, and how to deal 
with vested interests. Our first findings are published in a 
companion paper;40 
•	 collaborating with other disciplines such as public 
administration and political sciences, to learn from similar 
processes in other fields;41,42 
•	 experimenting with the implementation of processes in 
various contexts and evaluate these; and 
•	 stimulating the debate between researchers, policy-
makers, and society on the need to set legitimate priorities 
in healthcare.39
Conclusion
It is time to focus on the development of evidence-informed 
deliberative processes to set legitimate priorities, and we call for 
more research in this area. We believe that with such processes 
in place, priority setting can provide an important contribution 
to achieving UHC.
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